Related Experiment Video
Updated: Jul 1, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Scoring of disseminated intravascular coagulation (DIC) in intensive care medicine]
1Department of Internal Medicine, Central Hospital of Bolzano, Lorenz-Böhler-Street 5, 39100 Bolzano (BZ), Italy. christian.wiedermann@asbz.it
Insights
Newly developed scoring systems for disseminated intravascular coagulation (DIC) show a strong link between DIC and poor outcomes in critically ill patients. Early DIC detection via these scores may improve patient management and guide future treatment trials.
Area of Science:
- Critical Care Medicine
- Hematology
- Pathophysiology
Background:
- Disseminated intravascular coagulation (DIC) is associated with significant morbidity and mortality in critically ill patients.
- Current validation of new DIC scoring systems highlights this close association.
- Standardized quantification of pathological coagulation activation is crucial for patient management.
Purpose of the Study:
- To evaluate the role of novel DIC scoring systems in identifying patients at risk.
- To emphasize the potential of early DIC detection in critical illness management.
- To highlight the need for further research into therapeutic interventions for DIC.
Main Methods:
- Ongoing validation of newly developed DIC scoring systems.
- Analysis of the predictive power of DIC scores for morbidity and mortality.
- Review of existing data on antithrombin therapy for DIC.
Main Results:
- DIC scoring systems demonstrate a close association with increased morbidity and mortality in the critically ill.
- Early identification of DIC through scoring may widen the therapeutic window before irreversible organ failure.
- Randomized controlled trials on antithrombin for DIC treatment remain limited.
Conclusions:
- Novel DIC scores can aid in early detection and risk stratification of critically ill patients.
- Early DIC identification is vital for optimizing management strategies and potentially improving outcomes.
- Further research, particularly randomized controlled trials, is needed to establish effective DIC treatments like antithrombin therapy.
Abstract:
A close association between disseminated intravascular coagulation (DIC) and increased morbidity and mortality of the critically ill has been uncovered in the ongoing validation of newly developed scoring systems of DIC. DIC scoring aims at quantifying and standardizing pathological activation of coagulation in these patients. Because of the high predictive power of DIC scoring for morbidity and mortality, early identification of DIC may play an important role in the management of critical illness by widening of the therapeutic window before development of irreversible organ failure. Therapeutic intervention in DIC is not well studied. Promising data on targeted modification of DIC by administration of antithrombin has been reported in the past, however, randomized controlled trials on the use of antithrombin for the treatment of DIC are still few. Early detection of DIC by application of novel scores could play a particular role in future DIC trials by defining patient populations most likely to benefit from targeted intervention in their clotting disturbance of critical illness.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Acute Coronary Syndrome IV: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
